Therapeutic Goods Order No. 80 - Child-Resistant Packaging Requirements for Medicines (27/08/2008)
Part 3Alphabetical listing of entries
Start here
Get a plain-English read of Part 3
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods Order No. 80 - Child-Resistant Packaging Requirements for Medicines (27/08/2008).
(a) when packed in a container having a nominal capacity of 50 millilitres or less and fitted with a restricted flow insert; or
(b) in a preparation containing 50 per cent or less of anise oil, or a combination of anise oil and any other essential oil named in Part 2.
Antazoline (Antihistamines).
ANTIARRHYTHMICS.
ANTICHOLINERGICS.
ANTI‑DEMENTIA DRUGS.
ANTIDEPRESSANTS.
ANTIEMETICS AND ANTINAUSEANTS.
ANTIEPILEPTICS.
ANTIHISTAMINES.
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON‑STEROIDS.
ANTIMALARIALS, except doxycycline.
ANTINEOPLASTIC AGENTS.
ANTI‑PARKINSON DRUGS.
ANTIPSYCHOTICS.
ANTITHROMBOTIC AGENTS.
Apomorphine (Anti‑Parkinson Drugs).
Aprepitant (Antiemetics and Antinauseants).
Aripiprazole (Antipsychotics).
Arsenic trioxide (Antineoplastic Agents).
Artemether (Antimalarials).
Articaine (Anaesthetics, Local).
Aspirin.
Astemizole (Antihistamines).
Atenolol (Beta Blocking Agents).
Atomoxetine (Centrally Acting Sympathomimetics).
Atovaquone (Antimalarials).
Atropine (Anticholinergics).
Azadirachta indica (Neem), in a preparation for human dermal use containing more than 1 per cent of cold pressed neem seed oil.
Azatadine (Antihistamines).
Azelastine (Antihistamines).
Basil oil, except:
(a) when packed in a container having a nominal capacity of 25 millilitres or less and fitted with a restricted flow insert; or
Part Part 3 - Therapeutic Goods Order No. 80 - Child-Resistant Packaging Requirements for Medicines (27/08/2008) - Alphabetical listing of entries | Zoe
(b) in a preparation or oil containing 5 per cent or less of methyl chavicol.
Bay oil, except:
(a) when packed in a container having a nominal capacity of 15 millilitres or less and fitted with a restricted flow insert; or
(b) in a preparation containing 25 per cent or less of bay oil, or a combination of bay oil and any other essential oil named in Part 2.
Bendrofluazide (Diuretics).
Benzhexol (Anticholinergics; also Anti-Parkinson Drugs).
Benztropine (Anticholinergics; also Anti-Parkinson Drugs).
Benzocaine (Anaesthetics, Local).
BENZODIAZEPINE DERIVATIVES.
BENZODIAZEPINE RELATED DRUGS.
Benzydamine (Antiinflammatory and Antirheumatic Products, Non‑Steroids).
BETA BLOCKING AGENTS.
Betaxolol (Beta Blocking Agents).
Bevacizumab (Antineoplastic Agents).
Biperiden (Anticholinergics; also Anti-Parkinson Drugs).
Bisoprolol (Beta Blocking Agents).
Bleomycin (Antineoplastic Agents).
Bosentan.
Bretylium tosilate (Antiarrhythmics).
Bromazepam (Benzodiazepine Derivatives).
Bromhexine.
Bromocriptine (Anti‑Parkinson Drugs).
Brompheniramine (Antihistamines).
Bufexamac (Antiinflammatory and Antirheumatic Products, Non‑Steroids).
Bupivacaine (Anaesthetics, Local).
Buprenorphine (Opioids).
Busulfan (Antineoplastic Agents).
Butorphanol (Opioids).
Cabergoline (Anti‑Parkinson Drugs).
Cajuput oil, except:
(a) when packed in a container having a nominal capacity of 15 millilitres or less and fitted with a restricted flow insert; or
(b) in a preparation containing 25 per cent or less of cajuput oil, or a combination of cajuput oil and any other essential oil named in Part 2.
CALCIUM CHANNEL BLOCKERS.
Camphorated oil.
Camphor, except:
(a) in a liquid preparations containing 2.5 per cent or less of camphor;
(b) in an essential oil containing 10 per cent or less of camphor, packed in a container having a nominal capacity of 25 millilitres or less and fitted with a restricted flow insert;
(c) in an essential oil packed in a container having a nominal capacity of 15 millilitres or less and fitted with a restricted flow insert; or
(d) in rosemary oil, sage oil (Spanish), or lavandin oil as such.
Candesartan (Angiotensin II Antagonists).
Capecitabine (Antineoplastic Agents).
Captopril (ACE Inhibitors).
Carapichea ipecacuanha (Ipecacuanha).
Carbamazepine (Antiepileptics).
Carboplatin (Antineoplastic Agents).
CARDIAC GLYCOSIDES.
Carmustine (Antineoplastic Agents).
Carvedilol (Beta Blocking Agents).
Cassia oil, except in a preparation containing 2 per cent or less of cassia oil.
Celecoxib (Antiinflammatory and Antirheumatic Products, Non‑Steroids).
(a) when packed in a container having a nominal capacity of 15 millilitres or less and fitted with a restricted flow insert;
(b) in a preparation or oil containing 25 per cent or less of cineole; or
(c) in rosemary oil or camphor oil (white).
Cinnamon bark oil, except in a preparation containing 2 per cent or less of cinnamon bark oil.
Cinnamon leaf oil, except:
(a) when packed in a container having a nominal capacity of 15 millilitres or less and fitted with a restricted flow insert; or
(b) in a preparation containing 25 per cent or less of cinnamon leaf oil, or a combination of cinnamon leaf oil and any other essential oil named in Part 2.
Cisplatin (Antineoplastic Agents).
Citalopram (Antidepressants).
Cladribine (Antineoplastic Agents).
Clemizole (Antihistamines).
Clobazam (Benzodiazepine Derivatives).
Clomipramine (Antidepressants).
Clonazepam (Antiepileptics; also Benzodiazepine Derivatives).
Clonidine.
Clopidogrel (Antithrombotic Agents).
Clove oil, except:
(a) when packed in a container having a nominal capacity of 15 millilitres or less and fitted with a restricted flow insert;
(b) in a preparation containing 25 per cent or less of clove oil, or a combination of clove oil and any other essential oil named in Part 2.
Ibuprofen (Antiinflammatory and Antirheumatic Products, Non‑Steroids).
Ibutilide (Antiarrhythmics).
Idarubicin (Antineoplastic Agents).
Ifosfamide (Antineoplastic Agents).
Imatinib (Antineoplastic Agents).
Imipramine (Antidepressants).
Indapamide (Diuretics).
Indomethacin (Antiinflammatory and Antirheumatic Products, Non-Steroids).
Irbesartan (Angiotensin II Antagonists).
Irinotecan (Antineoplastic Agents).
Iron compounds, in a pack containing a total of more than 250 milligrams of elemental iron, except for divided preparations in which:
(a) the iron is compounded with one or more other active ingredients; and
(b) the amount of elemental iron per dosage unit is 5 milligrams or less.
However iron oxides that are present as an excipient, in either a divided preparation containing 10 milligrams or less of total iron oxides per dosage unit or an undivided preparation containing 1 per cent or less of total iron oxides, may be excluded from the calculation of elemental iron content.
Isradipine (Calcium Channel Blockers).
Ivabradine.
Ketoprofen (Antiinflammatory and Antirheumatic Products, Non‑Steroids).
Ketorolac (Antiinflammatory and Antirheumatic Products, Non‑Steroids).
Ketotifen (Antihistamines).
Labetalol (Beta Blocking Agents).
Lacosamide (Antiepileptics).
Lamotrigine (Antiepileptics).
Lanthanum.
Lapatinib (Antineoplastic Agents).
Lenalidomide.
Lercanidipine (Calcium Channel Blockers).
Levamisole (Antineoplastic Agents).
Levetiracetam (Antiepileptics).
Levobunolol (Beta Blocking Agents).
Levobupivacaine (Anaesthetics, Local).
Levocabastine (Antihistamines).
Levocetirazine (Antihistamines).
Levodopa (Anti‑Parkinson Drugs).
Lignocaine (Antiarrhythmics; also Anaesthetics, Local).
Lisinopril (ACE Inhibitors).
Lithium carbonate (Antipsychotics).
Lomustine (Antineoplastic Agents).
Loperamide (Opioids).
Loratadine (Antihistamines).
Lorazepam (Benzodiazepine Derivatives).
Lormetazepam (Benzodiazepine Derivatives).
Losartan (Angiotensin II Antagonists).
Lumefantrine (Antimalarials).
Lumiracoxib (Antiinflammatory and Antirheumatic Products, Non‑Steroids).
Marjoram oil, except:
(a) when packed in a container having a nominal capacity of 50 millilitres or less and fitted with a restricted flow insert; or
(b) in a preparation containing 50 per cent or less of marjoram oil, or a combination of marjoram oil and any other essential oil named in Part 2.
Meclozine (Antihistamines).
Mefenamic Acid (Antiinflammatory and Antirheumatic Products, Non‑Steroids).
Mefloquine (Antimalarials).
Melaleuca oil, except:
(a) when packed in a container having a nominal capacity of 15 millilitres or less and fitted with a restricted flow insert; or
(b) in a preparation containing 25 per cent or less of melaleuca oil, or a combination of melaleuca oil and any other essential oil named in Part 2.
Meloxicam (Antiinflammatory and Antirheumatic Products, Non‑Steroids).
Melphalan (Antineoplastic Agents).
Memantine (Anti‑Dementia Drugs).
Mepivacaine (Anaesthetics, Local).
Mepyramine (Antihistamines).
Mequitazine (Antihistamines).
Mercaptopurine (Antineoplastic Agents).
Metformin (Oral Blood Glucose Lowering Agents).
Methadone (Opioids).
Methdilazine (Antihistamines).
Methotrexate (Antineoplastic Agents).
Methyl aminolevulinate (Antineoplastic Agents).
Methyl salicylate, in a liquid preparation containing 5 per cent or more of methyl salicylate.